Moreover, Yonggang Wang et al identified that PKM2 inhibitor Shikonin overcomes the cisplatin resistance in BLCA by inducing necroptosis, which implied that downregulated necroptosis might facilitate the chemoresistance and progression51. This evidence concerns the gene PKM and bladder transitional cell carcinoma.